Published in Stroke on October 01, 1996
Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. Crit Care (2015) 1.42
Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care (2011) 1.22
Issues in selecting outcome measures to assess functional recovery after stroke. NeuroRx (2006) 1.18
The price of bouncing back: one-year mortality and payments for acute stroke patients with 30-day bounce-backs. J Am Geriatr Soc (2008) 1.09
Assessment scales in stroke: clinimetric and clinical considerations. Clin Interv Aging (2013) 0.98
Predictors of percutaneous endoscopic gastrostomy tube placement in patients with severe dysphagia from an acute-subacute hemispheric infarction. J Stroke Cerebrovasc Dis (2010) 0.97
Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke. Int J Mol Sci (2016) 0.87
Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome. Clin Interv Aging (2012) 0.86
NIHSS and acute complications after anterior and posterior circulation strokes. Ther Clin Risk Manag (2012) 0.85
Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men. J Neurol (2006) 0.84
Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study. PLoS One (2014) 0.82
Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory. J Clin Neurol (2005) 0.81
Association of laterality and size of perfusion lesions on neurological deficit in acute supratentorial stroke. Int J Stroke (2011) 0.80
Rehabilitation of the upper extremity and basic activities of daily living in the first month after ischemic stroke: an international cohort comparison study. Neurol Int (2009) 0.80
Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States. Stroke (2013) 0.78
The effect of statin therapy in stroke outcome: a double blind clinical trial. Int J Prev Med (2012) 0.78
Comparative efficacy of different acute reperfusion therapies for acute ischemic stroke: a comprehensive benefit-risk analysis of clinical trials. Brain Behav (2014) 0.78
Is the NIHSS certification process too lenient? Cerebrovasc Dis (2009) 0.78
The Prediction of Clinical Outcome Using HbA1c in Acute Ischemic Stroke of the Deep Branch of Middle Cerebral Artery. Ann Rehabil Med (2015) 0.78
Risk factors for acute stroke among South Asians compared to other racial/ethnic groups. PLoS One (2014) 0.77
Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study. Int J Mol Sci (2015) 0.77
Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study. BMC Neurol (2015) 0.76
Impact of corticofugal fibre involvement in subcortical stroke. BMJ Open (2013) 0.76
Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin. J Transl Med (2012) 0.76
Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II? PLoS One (2016) 0.75
Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease. PLoS One (2015) 0.75
A left MCA territory infarction during intravenous recombinant tissue plasminogen activator therapy for right MCA territory ischaemic stroke. Emerg Med J (2006) 0.75
Carotid stenting in a nonagenarian patient with symptomatic carotid stenosis. Australas Med J (2012) 0.75
Predictors of extubation success in acute ischemic stroke patients. J Neurol Sci (2016) 0.75
Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke. J Korean Med Sci (2016) 0.75
Maximizing efficiency and diagnostic accuracy triage of acute stroke patients: A case-control study. Interv Neuroradiol (2016) 0.75
EPO-cyclosporine combination therapy reduced brain infarct area in rat after acute ischemic stroke: role of innate immune-inflammatory response, micro-RNAs and MAPK family signaling pathway. Am J Transl Res (2017) 0.75
A novel effect of Noscapine on patients with massive ischemic stroke: A pseudo-randomized clinical trial. Iran J Neurol (2015) 0.75
Neurology in practice: cerebrovascular disease. J Neurol Neurosurg Psychiatry (2001) 0.75
Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke. Ann Clin Transl Neurol (2017) 0.75
Ischemic stroke: the impact of renal dysfunction on 1-year mortality. Wien Klin Wochenschr (2015) 0.75
Elevated serum IL-11, TNF α, and VEGF expressions contribute to the pathophysiology of hypertensive intracerebral hemorrhage (HICH). Neurol Sci (2016) 0.75
Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale. Interv Neurol (2016) 0.75
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
THE USE OF HEPARIN IN THROMBOSIS. Ann Surg (1938) 6.65
Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet (2000) 5.77
Comparison of UK paediatric cardiac surgical performance by analysis of routinely collected data 1984-96: was Bristol an outlier? Lancet (2001) 5.26
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens (1998) 4.94
Disability in young people and adults one year after head injury: prospective cohort study. BMJ (2000) 4.87
White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Psychological support for patients undergoing breast cancer surgery: a randomised study. BMJ (1996) 4.11
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ (1997) 3.88
Anticardiolipin antibodies in an unselected stroke population. Lancet (1994) 3.66
Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology (2000) 3.64
Influence of cholesterol on survival after stroke: retrospective study. BMJ (1997) 3.64
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 3.32
Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet (1994) 3.03
Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) (1983) 2.90
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
Does prediction of outcome alter patient management? Lancet (1993) 2.75
Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis (2006) 2.74
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet (2003) 2.64
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet (2004) 2.51
Comparison of manually constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland Anastomosis Study Group. Ann Surg (1995) 2.30
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology (2011) 2.24
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Comparison of two methods for predicting difficult intubation. Br J Anaesth (1991) 1.92
Factors influencing tackle injuries in rugby union football. Br J Sports Med (1999) 1.88
Service provision for people with schizophrenia. II. Role of the general practitioner. Br J Psychiatry (1997) 1.88
Record linked retrospective cohort study of 4.6 million people exploring ethnic variations in disease: myocardial infarction in South Asians. BMC Public Health (2007) 1.88
Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery. Br J Anaesth (2001) 1.87
Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM (2000) 1.84
Beds occupied by emergency patients: long-term trends in patterns of short-term fluctuation in Scotland. Health Bull (Edinb) (1997) 1.67
Intensive care management of head-injured patients in Europe: a survey from the European brain injury consortium. Intensive Care Med (2001) 1.67
The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain (2005) 1.67
Comparing outcomes of percutaneous transluminal coronary angioplasty with coronary artery bypass grafting; can routine health service data complement and enhance randomized controlled trials? Eur Heart J (1999) 1.66
The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. BJOG (2010) 1.59
The value of the "worst" computed tomographic scan in clinical studies of moderate and severe head injury. European Brain Injury Consortium. Neurosurgery (2000) 1.47
Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke (2000) 1.47
Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med (1984) 1.46
Association of fibrinolytic tests with outcome of acute upper-gastrointestinal-tract bleeding. Lancet (1993) 1.45
Functional outcome measures in contemporary stroke trials. Int J Stroke (2009) 1.43
C-reactive protein and outcome after ischemic stroke. Stroke (1999) 1.42
Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry (2003) 1.41
Secondary hypertension in a blood pressure clinic. Arch Intern Med (1987) 1.41
Disability in young people and adults after head injury: 5-7 year follow up of a prospective cohort study. J Neurol Neurosurg Psychiatry (2006) 1.40
Reprinted article "The fate of the claudicant--a prospective study of 1969 claudicants". Eur J Vasc Endovasc Surg (2011) 1.39
Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women. Climacteric (2005) 1.38
Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J (1993) 1.36
The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer (1991) 1.35
Clinical experience with excitatory amino acid antagonist drugs. Stroke (1995) 1.33
Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens (1988) 1.31
Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM (2000) 1.27
Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax (2008) 1.26
Evaluation of designs for clinical trials of neuroprotective agents in head injury. European Brain Injury Consortium. J Neurotrauma (1999) 1.26
A comparison of reports from referees chosen by authors or journal editors in the peer review process. Ann R Coll Surg Engl (2000) 1.17
The fate of the claudicant--a prospective study of 1969 claudicants. Eur J Vasc Surg (1991) 1.17
ACE inhibitors after myocardial infarction. Lancet (1994) 1.17
Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence? Int J Colorectal Dis (1991) 1.15
A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis (2006) 1.15
A two-centred pragmatic randomised controlled trial of two interventions of postnatal support. BJOG (2002) 1.13
Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke (1999) 1.12
Audit of screening programme for congenital hypothyroidism in Scotland 1979-93. Arch Dis Child (1997) 1.10
Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. Br J Clin Pharmacol (1984) 1.10
Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertens Suppl (1983) 1.09
Using routine data to complement and enhance the results of randomised controlled trials. Health Technol Assess (2000) 1.08
Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic. J Hypertens (1990) 1.07
Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke (1989) 1.07
Psychological morbidity in the first year after breast surgery. Eur J Surg Oncol (1992) 1.07
Is lead in tap water still a public health problem? An observational study in Glasgow. BMJ (1996) 1.07
The experiences of an acute stroke unit--implications for multicentre acute stroke trials. J Neurol Neurosurg Psychiatry (1993) 1.06
Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes. Eur J Clin Pharmacol (1986) 1.05
The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions. J Cardiovasc Pharmacol (1991) 1.04
Outcome assignment in the International Surgical Trial of Intracerebral Haemorrhage. Acta Neurochir (Wien) (2003) 1.04
Death after head injury: the 13 year outcome of a case control study. J Neurol Neurosurg Psychiatry (2011) 1.04
Peroneal stimulator; evaluation for the correction of spastic drop foot in hemiplegia. Arch Phys Med Rehabil (1996) 1.03
Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol (1996) 1.03
The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke (1998) 1.03
The prognostic value of the components of the Glasgow Coma Scale following acute stroke. QJM (2003) 1.03
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. Br J Clin Pharmacol (1987) 1.02
Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer (1992) 1.01
Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand (2003) 1.00
The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. Br J Clin Pharmacol (1983) 1.00
Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency. Arch Dis Child (1994) 1.00
Domiciliary occupational therapy for patients with stroke discharged from hospital: randomised controlled trial. BMJ (2000) 1.00
Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke (1998) 1.00
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J (1991) 1.00
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (1997) 0.99
A recognition tool for transient ischaemic attack. QJM (2008) 0.99